We previously demonstrated in 81 patients that mTICI2b reperfusion resulted in worse mean mRS at discharge and 90 days compared to mTICI 2c/3. To improve the study's power, we performed a retrospective review of AIS patients who received EVT at our comprehensive stroke center from 1/1/22–6/25/25. Using the institutional Get-With-The-Guidelines registry, 455 patients with LVO treated to mTICI ≥2b were identified. Two blinded endovascular neurosurgeons reviewed digital subtraction angiograms to assign mTICI scores. Of the 455, 403 met criteria and modified Rankin Scores (mRS) at 24h and 90 days post-EVT were available for 323 cases. Primary outcome measures included 24h and 90-day median mRS and standard deviation. Secondary outcome measures included functional independence (mRS 0-2), ambulation (mRS 0-3), death and disability (mRS 4-6), and death (mRS = 6) at 24h and 90 days.